The only other FDA-approved product to slow myopia are contact lenses made by a company called MiSight. The daily disposable ...
Jaguar’s requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia® A ...
A new drug that treats adults with acute myeloid leukemia, and three years after Roswell enrolled the first patient to use ...
The FDA has approved an adeno-associated virus 9 gene replacement therapy to treat individuals aged 2 years and older with ...
Phoenix NP announced an expansion of its service availability across Arizona to help more women access FDA-approved GLP-1 weight loss medications through compliant, manufacturer-direct pharmacies. The ...
FDA Approves Stellest Lens for Kids, Which Can Slow Myopia Progression by Up to 70%. Learn How These New Glasses Protect ...
A San Diego medical technology company received FDA approval this morning for a device that could transform how patients get ...
FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients ...
In March 2025, the FDA approved OMLYCLO in 75 mg/0.5 mL and 150 mg/mL solutions in a single-dose prefilled syringe for subcutaneous injection for the treatment of moderate to severe persistent asthma, ...
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05%, which is is the generic equivalent of RESTASIS 0.05%, a registered trademark of ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...
A once-beleaguered gene-therapy stock just landed a major vote of confidence—and the timing seems anything but accidental.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback